Ares Financial Consulting’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Buy
318
+8
+3% +$3.19K 0.09% 117
2026
Q2
$112K Buy
310
+9
+3% +$3.08K 0.08% 139
2026
Q1
$106K Buy
301
+197
+189% +$70.2K 0.08% 128
2025
Q4
$34K Buy
+104
New +$33K 0.03% 202

Other funds holding AMGN

Ares Financial Consulting's AMGN Position: Q3 2026 in Review

Ares Financial Consulting increased its Amgen (AMGN) stake by 2.6% in Q3 2026, buying an estimated $3.19K and bringing the position to 318 shares worth $134K. The position accounts for 0.09% of the portfolio, ranked #117.

Ares Financial Consulting first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,039 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Ares Financial Consulting held 318 shares of Amgen worth $134K as of Q3 2026.
  • Ares Financial Consulting bought 8 Amgen shares in Q3 2026, an estimated $3.19K.
  • Amgen made up 0.09% of Ares Financial Consulting's portfolio in Q3 2026, its #117 holding.
  • Ares Financial Consulting first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,039 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.